Implant Brands Explained: Tiers, Hydrophilic Surfaces, and What Actually Matters

Straumann, Nobel, Osstem, Dentium - what is the real difference? Does a hydrophilic surface like SLActive actually heal faster? A look at the human clinical data, and an honest answer on who genuinely needs to pay for it.

Implant Dentist

8/23/20267 min read

man in white dress shirt holding black pen
man in white dress shirt holding black pen

Implant Brands Explained: Tiers, Hydrophilic Surfaces, and What Actually Matters

The line on your quote that you skipped

When most people receive an implant quote, their eyes go straight to the number at the bottom.

But the line that will actually shape the next twenty years of your mouth is the small print in the middle: the implant brand and the catalogue number.

Ask what the difference is, and you generally get one of two answers. The clinic says this one is better. The internet says they are all much the same and you are paying for a logo.

Neither answer is complete.

This article explains what genuinely separates implant systems: how the brand tiers work, what a hydrophilic surface actually changes, and — the part almost nobody tells you — who genuinely benefits from paying extra for it, and who is buying something they will never use.

First, a correction: brand tier is not the same as success rate

This needs to be established before anything else.

Modern mainstream implant systems, European or Korean, generally report ten-year survival rates above 95% for straightforward single-tooth cases. You do not move from "works" to "fails" by choosing a second-tier brand.

So what does the tier actually buy you? Two things.

One: performance under difficult conditions. Insufficient bone, immediate placement, immediate loading, patients with impaired healing. These edge cases are where the depth of a brand's clinical evidence genuinely separates it from the rest.

Two: whether the parts still exist in fifteen years.

The second one is the risk almost everyone underestimates, and it deserves its own section.

The three tiers, roughly

Tier one: the established Western systems

Straumann (Switzerland), Nobel Biocare (Sweden, Envista Group), Astra Tech (Dentsply Sirona), Zimmer Biomet, BioHorizons (US).

Straumann Group held the number one position in the global implant and abutment market in 2025, with Envista second. What this tier shares is thirty-plus years of clinical follow-up data, a research base covering complex cases, and a global supply network for components and prosthetic parts.

A significant portion of the premium is buying depth of evidence and supply-chain longevity.

Tier two: the value workhorses

Osstem (Korea), Dentium (Korea), MegaGen (Korea), Neodent (Brazil, Straumann Group), Implant Direct (Envista Group).

Osstem is among the most widely used implant systems in Asia by volume, holding over 80% of its home Korean market. Korean systems are designed around Asian alveolar bone morphology, with tapered geometry and thread designs that favour primary stability, and they carry complete component ecosystems.

Worth noting: Neodent and Implant Direct belong to the Straumann and Envista groups respectively. You are buying group-level supply chain assurance at a different price point. For most patients, this is the lowest-risk way to sit in tier two.

Tier three: regional and domestic brands

Locally manufactured systems and smaller producers.

The concern here is not "does it work today." It is "will this company still exist in fifteen years."

Shorter clinical record, limited international distribution, and parts availability dependent on a single local agent. The engineering may be perfectly sound. What it does is transfer a timing risk onto you.

The "implant orphan": the concept to remember from this article

There is a term used in dentistry — the implant orphan — and it describes the risk precisely.

To understand it, separate two components:

  • The fixture — the screw in your jawbone. Ideally it never moves again.

  • The crown and abutment — the visible part. This is a consumable.

Crowns wear. Crowns chip. Needing a replacement after fifteen or twenty years is entirely normal. But to fit a new crown, your dentist needs an abutment that precisely matches your specific fixture.

If by then the manufacturer has folded, the system has been discontinued, or you have moved somewhere with no local distributor — you are an orphan. The remaining option is often to surgically remove the fixture and start over: more expensive, more painful, and considerably longer than the original procedure.

So the question to ask is not "is this brand good." It is:

  • Is this brand formally distributed in Malaysia?

  • If I relocate to Singapore, Australia or the UK in ten years, can a dentist there source the parts?

  • How large is this company, and how long has it existed?

Those three answers matter more than any marketing claim you will read.

Surface treatment: where the actual engineering happens

If the brand tells you who made it, the surface treatment tells you how. This is where implant technology has genuinely advanced over the past few decades.

Three generations, broadly:

First generation: machined smooth surfaces. Slow integration, limited contact area. Obsolete.

Second generation: roughened surfaces. The current industry standard. The best known is SLA — Sandblasted, Large-grit, Acid-etched. Titanium is blasted with large corundum particles, then etched with sulphuric and hydrochloric acid, creating micron-scale roughness that substantially increases bone-to-implant contact area.

Third generation: hydrophilic surfaces. Straumann's SLActive is the reference product. Others include Osstem's CA surface and Neodent's Acqua.

What a hydrophilic surface actually does

The difference is in the final manufacturing step, and it is smaller than you would expect.

SLActive and SLA start identically: same cold-worked titanium, same sandblasting, same acid etch. The difference is that SLActive is rinsed under protective nitrogen gas, never exposed to air, then sealed in a tube of isotonic saline solution.

Avoiding air contact prevents carbon contamination of the surface. Measurements put the carbon contamination film on SLActive at around 0.8 nanometres, versus roughly 1.6 nanometres on SLA.

The result is higher surface energy and greater wettability. When the implant contacts blood, the blood spreads instantly across the entire surface rather than beading, the clot adheres faster, and bone cells engage sooner.

A rough analogy: a drop of water on a freshly waxed car beads up. On clean glass it spreads flat. A hydrophilic surface is the glass.

So how much faster is it, honestly?

Marketing material will tell you it significantly accelerates early bone healing. That statement is true, and it omits the part that matters most.

Here is the actual human data.

One study placed test implants in the retromolar region of 49 human volunteers and retrieved them at 7, 14, 28 and 42 days to measure bone-to-implant contact (BIC):

  • At 2 weeks — SLActive 14.8%, SLA 12.2%

  • At 4 weeks — SLActive 48.3%, SLA 32.4%. This is the widest the gap gets.

  • At 42 days (6 weeks) — SLActive 61.6%, SLA 61.5%

Read that third line again. By six weeks, they are effectively identical.

Animal studies show the same pattern repeatedly. In dogs, the hydrophilic surface led significantly at 2 weeks with the difference gone by 4 weeks. In sheep, it led at 3 weeks with no significant difference by 6 weeks.

Then the higher-tier evidence. A 2023 systematic review pooled six randomised controlled trials covering 326 implants, comparing implant stability (ISQ) between the two surfaces over 12 weeks. Its conclusion: stability was comparable between the two.

And on reviewing the available human research, the academic assessment has been that current clinical evidence is not sufficient to clearly establish a preference for the hydrophilic surface over standard roughened surfaces.

What that adds up to

A hydrophilic surface buys you speed in the first four weeks. It does not buy you a higher final success rate.

This is not a dismissal of the technology — it is a real advance, and the mechanism is sound. But it forces the next question:

Is speed in the first four weeks useful to you?

When it is worth paying for, and when it is not

Situations where a hydrophilic surface may genuinely earn its cost

Immediate placement or immediate loading. Placing the fixture at the same appointment as the extraction, or loading it with bite force soon after. These protocols are most fragile in exactly the first few weeks — the one window where the hydrophilic surface leads.

Poor bone quality. Soft Type IV bone in the posterior maxilla, or areas with reduced density. The hydrophilic surface has been observed to reduce the stability dip that normally occurs during the remodelling phase.

Impaired healing capacity. Smokers, diabetics, immunosuppressed patients, and those with a history of radiotherapy. Healing in these groups is slower and less predictable, so an early advantage is worth having.

When shortening the treatment timeline has real financial value to you. If you are travelling for treatment or your time away from work is expensive, cutting two to four weeks off the timeline may save an entire trip. That is a genuine economic benefit, not a clinical one — but it counts.

Situations where you are probably just paying more

Good bone, a single missing tooth, conventional delayed loading.

The logic is simple. Under a conventional protocol you are waiting three to four months for the crown regardless. Since both surfaces have converged by week six, the speed advantage in weeks one to four is one you never use. It sits quietly in your jaw, finishes early, and then waits for you.

You paid for acceleration you did not consume.

Three things that matter more than brand or surface

Having explained the technology, here is the part that does not sit comfortably in marketing copy:

In the great majority of routine cases, how fluent your dentist is with a given system matters more than which brand it is.

The reason is practical. Every implant system has its own drill sequence, insertion torque protocol, and prosthetic component logic. A dentist who has placed Osstem for ten years will very likely produce a better result with Osstem than with a Straumann system they are handling for the first time. A tool cannot outperform the person using it.

Two other things also outrank brand:

Digital planning before surgery. Whether a CBCT scan is taken and whether placement is planned in 3D. A clinician who plans an implant from a single 2D panoramic film alone makes the brand question secondary.

A verifiable serial number and warranty card. Any legitimate implant should come with a manufacturer card carrying a scannable code showing the model, batch and production date. That card is your insurance for the next twenty years. Keep it somewhere you will find it.

Five questions to ask at your consultation

One. Which brand, which model, and which surface treatment are you recommending?

Two. Why this one? A good answer connects to your bone condition and treatment protocol, not to "this is the best one."

Three. What would a different tier cost, and what would change? You are entitled to know what you are paying for.

Four. Is this brand formally distributed in Malaysia? If I need a replacement crown in ten years, how easily are the parts sourced?

Five. Will I receive the manufacturer serial number and warranty card?

The point

An implant brand is not better because it costs more. It is better when it matches your bone, your treatment protocol, and the next twenty years of your life.

Someone with good bone, one missing tooth, who expects to live in the same city indefinitely, is making an entirely sound decision by choosing a mature tier-two Korean system.

Someone having immediate loading, with a smoking history, who may relocate abroad, is making an equally sound decision by paying for tier one with a hydrophilic surface.

Same question. Opposite answers. Both correct.

The only thing that separates them is whether the right questions got asked.

This article is general educational and technical information. It is not medical or dental advice and does not recommend any particular brand, product or provider. Research figures cited are from published academic literature. The implant system appropriate for you must be determined by a qualified dentist following clinical examination and imaging.

Last updated: August 2026

Dental Implant Asia

亞洲植牙

Cost-effective dental implants and porcelain veneers solutions.

高性價比的植牙與全瓷貼片解決方案。

Consultation 咨詢

Your Contact 你的聯絡

© 2025. All rights reserved.